Literature DB >> 17987289

Neuroprotective effects of riluzole in Huntington's disease.

Ferdinando Squitieri, Andrea Ciammola, Claudio Colonnese, Andrea Ciarmiello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17987289     DOI： 10.1007/s00259-007-0615-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  6 in total

1.  Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach.

Authors:  B Alfano; A Brunetti; E M Covelli; M Quarantelli; M R Panico; A Ciarmiello; M Salvatore
Journal:  Magn Reson Med       Date:  1997-01       Impact factor: 4.668

2.  Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.

Authors:  Andrea Ciarmiello; Milena Cannella; Secondo Lastoria; Maria Simonelli; Luigi Frati; David C Rubinsztein; Ferdinando Squitieri
Journal:  J Nucl Med       Date:  2006-02       Impact factor: 10.057

3.  Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.

Authors:  Laurent R Gauthier; Bénédicte C Charrin; Maria Borrell-Pagès; Jim P Dompierre; Hélène Rangone; Fabrice P Cordelières; Jan De Mey; Marcy E MacDonald; Volkmar Lessmann; Sandrine Humbert; Frédéric Saudou
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

4.  Co-treatment with riluzole and GDNF is necessary for functional recovery after ventral root avulsion injury.

Authors:  Astrid Bergerot; Peter J Shortland; Praveen Anand; Stephen P Hunt; Thomas Carlstedt
Journal:  Exp Neurol       Date:  2004-06       Impact factor: 5.330

5.  Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus.

Authors:  Ritsuko Katoh-Semba; Tomiko Asano; Hiroshi Ueda; Rika Morishita; Ikuo K Takeuchi; Yutaka Inaguma; Kanefusa Kato
Journal:  FASEB J       Date:  2002-06-21       Impact factor: 5.191

6.  Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients.

Authors:  A Ciammola; J Sassone; M Cannella; S Calza; B Poletti; L Frati; F Squitieri; V Silani
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-06-05       Impact factor: 3.568
  6 in total
  6 in total

Review 1.  Molecular medicine: predicting and preventing Huntington's disease.

Authors:  Ferdinando Squitieri; Milena Cannella; Luigi Frati
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

Review 2.  Nanoparticles in the brain: a potential therapeutic system targeted to an early defect observed in many neurodegenerative diseases.

Authors:  Shermali Gunawardena
Journal:  Pharm Res       Date:  2013-04-27       Impact factor: 4.200

3.  Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins.

Authors:  Ferdinando Squitieri; Sara Orobello; Milena Cannella; Tiziana Martino; Pantaleo Romanelli; Giampiero Giovacchini; Luigi Frati; Luigi Mansi; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-11       Impact factor: 9.236

4.  Lack of riluzole efficacy in the progression of the neurodegenerative phenotype in a new conditional mouse model of striatal degeneration.

Authors:  Grzegorz Kreiner; Katarzyna Rafa-Zabłocka; Piotr Chmielarz; Monika Bagińska; Irena Nalepa
Journal:  PeerJ       Date:  2017-04-27       Impact factor: 2.984

Review 5.  The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases.

Authors:  Anne-Claire Dupont; Bérenger Largeau; Denis Guilloteau; Maria Joao Santiago Ribeiro; Nicolas Arlicot
Journal:  Contrast Media Mol Imaging       Date:  2018-05-17       Impact factor: 3.161

6.  Early defect of transforming growth factor β1 formation in Huntington's disease.

Authors:  Giuseppe Battaglia; Milena Cannella; Barbara Riozzi; Sara Orobello; Marion L Maat-Schieman; Eleonora Aronica; Carla Letizia Busceti; Andrea Ciarmiello; Silvia Alberti; Enrico Amico; Jenny Sassone; Simonetta Sipione; Valeria Bruno; Luigi Frati; Ferdinando Nicoletti; Ferdinando Squitieri
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.